Prestwick3_000012

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

9 Suppliers, 7 USDMF, 1 KDMF, 5 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

DOSSIERs // Finished Dosage Forms

40 Dossiers, 34 FDA Orange Book, 6 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 19 Roquette, 9 Sigachi Industries, 7 Gangwal Healthcare, 5 Gangwal Chemicals, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 SPI Pharma, 4 Kerry, 3 Lonza Capsugel, 3 DFE Pharma, 2 Prachin Chemical, 2 Nanjing Well Pharmaceutical, 2 BASF, 2 Actylis, 2 Microlex e.U, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Vasa Pharmachem, 1 Qualicaps, 1 Ingredion Pharma Solutions, 1 Rochem International Inc, 1 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Pharmatrans-Sanaq, 1 Finar, 1 DKSH, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 15 Disintegrants & Superdisintegrants, 13 Direct Compression, 12 Film Formers & Plasticizers, 10 Thickeners and Stabilizers, 9 Coating Systems & Additives, 8 Empty Capsules, 7 Granulation, 7 Taste Masking, 7 Co-Processed Excipients, 5 Controlled & Modified Release, 5 Parenteral, 4 Chewable & Orodispersible Aids, 3 Topical, 3 Lubricants & Glidants, 2 Solubilizers, 2 Rheology Modifiers, 1 Soft Gelatin, 1 Emulsifying Agents, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

6 APIs

6 APIs

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

7 News

7 News

Approved Drug Products containing Prestwick3_000012 listed in the FDA Orange Book. Original Data : FDA Website

Prestwick3_000012

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

9 Suppliers

7 USDMF

1 KDMF

5 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

DOSSIERs // Finished Dosage Forms

40 Dossiers

34 FDA Orange Book

6 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 100MG

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

19 Roquette

9 Sigachi Industries

7 Gangwal Healthcare

5 Gangwal Chemicals

4 ACG Worldwide

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 SPI Pharma

4 Kerry

3 Lonza Capsugel

3 DFE Pharma

2 Prachin Chemical

2 Nanjing Well Pharmaceutical

2 BASF

2 Actylis

2 Microlex e.U

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Vasa Pharmachem

1 Qualicaps

1 Ingredion Pharma Solutions

1 Rochem International Inc

1 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Pharmatrans-Sanaq

1 Finar

1 DKSH

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

15 Disintegrants & Superdisintegrants

13 Direct Compression

12 Film Formers & Plasticizers

10 Thickeners and Stabilizers

9 Coating Systems & Additives

8 Empty Capsules

7 Granulation

7 Taste Masking

7 Co-Processed Excipients

5 Controlled & Modified Release

5 Parenteral

4 Chewable & Orodispersible Aids

3 Topical

3 Lubricants & Glidants

2 Solubilizers

2 Rheology Modifiers

1 Soft Gelatin

1 Emulsifying Agents

1 API Stability Enhancers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

4 Finished Drug Prices

MARKET PLACE

6 APIs

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods

1 USP Standards

1 Other Ref. Standards

CAPSULE;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons